Synthesis of 2',3'-dideoxynucleoside 5'-alpha-P-borano-beta,gamma-(difluoromethylene)triphosphates and their inhibition of HIV-1 reverse transcriptase. 2005

Nicholas A Boyle, and Vivek K Rajwanshi, and Marija Prhavc, and Guangyi Wang, and Patrick Fagan, and Fu Chen, and Gregory J Ewing, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Thomas W Bruice, and P Dan Cook
Research Laboratories, Biota, Inc., 2232 Rutherford Road, Carlsbad, California 92008, USA.

The triphosphates of antiviral 2',3'-dideoxynucleosides (ddNs) are the active chemical species that inhibit viral DNA synthesis. The inhibition involves incorporation of ddNMP into DNA and subsequent chain termination. A conceivable strategy for antiviral drugs is to employ nucleoside 5'-triphosphate mimics that can entirely bypass cellular phosphorylation. AZT 5'-alpha-R(P)-borano-beta,gamma-(difluoromethylene)triphosphate (5'-alphaB-betagammaCF(2)TP) has been identified as a potent inhibitor of HIV-1 reverse transcriptase (HIV-1 RT). This work was aimed at confirming that 5'-alphaB-betagammaCF(2)TP is a useful generic triphosphate moiety and can render antiviral ddNs with potent inhibitory effects on HIV-1 RT. Thus, 10 ddNs were converted to their 5'-alphaB-betagammaCF(2)TPs via a sequence (one-pot) of reactions: formation of an activated phosphite, formation of a cyclic triphosphate, boronation, and hydrolysis. Other synthetic routes were also explored. All ddN 5'-alphaB-betagammaCF(2)TPs tested exhibited essentially the same level of inhibition of HIV-1 RT as the corresponding ddNTPs. A conclusion can be made that 5'-alphaB-betagammaCF(2)TP is a generic and promising triphosphate mimic (P3M) concerning HIV-1 RT inhibition and serum stability. It is anticipated that use of 5'-alphaB-betagammaCF(2)TP as P3M moiety will lead to the discovery of a new class of anti-HIV agents.

UI MeSH Term Description Entries
D001896 Boron Compounds Inorganic or organic compounds that contain boron as an integral part of the molecule. Borides,Compounds, Boron
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D003854 Deoxyribonucleotides A purine or pyrimidine base bonded to a DEOXYRIBOSE containing a bond to a phosphate group. Deoxyribonucleotide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

Nicholas A Boyle, and Vivek K Rajwanshi, and Marija Prhavc, and Guangyi Wang, and Patrick Fagan, and Fu Chen, and Gregory J Ewing, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Thomas W Bruice, and P Dan Cook
January 2005, Nucleosides, nucleotides & nucleic acids,
Nicholas A Boyle, and Vivek K Rajwanshi, and Marija Prhavc, and Guangyi Wang, and Patrick Fagan, and Fu Chen, and Gregory J Ewing, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Thomas W Bruice, and P Dan Cook
December 1987, Biochemical pharmacology,
Nicholas A Boyle, and Vivek K Rajwanshi, and Marija Prhavc, and Guangyi Wang, and Patrick Fagan, and Fu Chen, and Gregory J Ewing, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Thomas W Bruice, and P Dan Cook
March 2010, Organic & biomolecular chemistry,
Nicholas A Boyle, and Vivek K Rajwanshi, and Marija Prhavc, and Guangyi Wang, and Patrick Fagan, and Fu Chen, and Gregory J Ewing, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Thomas W Bruice, and P Dan Cook
March 2003, Nucleosides, nucleotides & nucleic acids,
Nicholas A Boyle, and Vivek K Rajwanshi, and Marija Prhavc, and Guangyi Wang, and Patrick Fagan, and Fu Chen, and Gregory J Ewing, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Thomas W Bruice, and P Dan Cook
April 1999, Nucleic acids research,
Nicholas A Boyle, and Vivek K Rajwanshi, and Marija Prhavc, and Guangyi Wang, and Patrick Fagan, and Fu Chen, and Gregory J Ewing, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Thomas W Bruice, and P Dan Cook
September 2000, Biochemistry,
Nicholas A Boyle, and Vivek K Rajwanshi, and Marija Prhavc, and Guangyi Wang, and Patrick Fagan, and Fu Chen, and Gregory J Ewing, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Thomas W Bruice, and P Dan Cook
August 1998, The Journal of organic chemistry,
Nicholas A Boyle, and Vivek K Rajwanshi, and Marija Prhavc, and Guangyi Wang, and Patrick Fagan, and Fu Chen, and Gregory J Ewing, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Thomas W Bruice, and P Dan Cook
October 1995, The Journal of biological chemistry,
Nicholas A Boyle, and Vivek K Rajwanshi, and Marija Prhavc, and Guangyi Wang, and Patrick Fagan, and Fu Chen, and Gregory J Ewing, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Thomas W Bruice, and P Dan Cook
January 2005, Nucleosides, nucleotides & nucleic acids,
Nicholas A Boyle, and Vivek K Rajwanshi, and Marija Prhavc, and Guangyi Wang, and Patrick Fagan, and Fu Chen, and Gregory J Ewing, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Thomas W Bruice, and P Dan Cook
December 1989, Antiviral research,
Copied contents to your clipboard!